|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Thoracic Surgery (Drs. Kurimoto and Okimasa) and Respiratory Medicine (Drs. Maeda and Oiwa), National Hiroshima Hospital, Hiroshima; Department of Respiratory Medicine (Drs. Miyazawa and Miyazu), Hiroshima City Hospital, Hiroshima; and Department of Surgery (Dr. Murayama), Iwakuni Minami Hospital, Iwakuni, Japan.
Correspondence to: Noriaki Kurimoto, MD, 513 Jike, Saijyoucyou, Higashi-hiroshima City, Hiroshima Prefecture, 739-0041 Japan; e-mail; n.kurimoto{at}do7.enjoy.ne.jp
| Abstract |
|---|
|
|
|---|
Method: We devised a technique for EBUS-GS covering a miniature probe, and 150 lesions were evaluated in a prospective open study. In this procedure, the probe covered by a guide sheath is introduced into the lesion via the working channel of a bronchoscope. The probe is withdrawn, while the guide sheath is left in situ. A brush or biopsy forceps is introduced through the guide sheath into the lesion.
Results: One hundred sixteen of 150 EBUS-GS procedures (77%) were diagnostic. Cases in which the probe was located within the lesion had a significantly higher diagnostic yield (105 of 121 cases, 87%) than when the probe was located adjacent to it (8 of 19 cases, 42%) [p < 0.0001,
2]. The diagnostic yield from EBUS-GS in lesions
10 mm (16 of 21 lesions, 76%), >10 to
15 mm (19 of 25 lesions, 76%; p = 0.99,
2), >15 to
20 mm (23 of 35 lesions, 66%; p = 0.41,
2), and > 20 to
30 mm (33 of 43 lesions, 77%; p = 0.96,
2) were similar, demonstrating the efficacy of EBUS-GS even in lesions
10 mm in diameter. In 54 of 81 lesions
20 mm, fluoroscopy was not able to confirm whether the forceps reached the lesion. However, the yield was the same with (67%, 18 of 27 lesions) and without (74%, 40 of 54 lesions) successful fluoroscopy (p = 0.96,
2). Moderate bleeding occurred in two patients (1%); there were no other complications.
Conclusions: EBUS-GS is a useful method for collecting samples from peripheral pulmonary lesions, even those too small to be visualized under fluoroscopy.
Key Words: endobronchial ultrasonography guide sheath peripheral pulmonary lesions
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Equipment
A miniature ultrasound probe (20 MHz, mechanical-radial type) [UM-S2020R; Olympus Optical; Tokyo, Japan] with an outer diameter of 1.7 mm was used. The probe was connected to an endoscopic ultrasound system (EU-M30; Olympus Optical). A guide sheath (Olympus Optical) was manufactured especially for this purpose.
Preparation
A bronchial brush (BC-202D-5010; Olympus Optical) or biopsy forceps (BF-19C-1; Olympus Optical) for TBB is introduced into the specially made guide sheath, so that the tip of the forceps reaches the far end of the sheath to facilitate manipulation (Fig 1
, top right, 1). The forceps is marked at the near end of the sheath by cellulose tape during bronchoscopy. A miniature probe is introduced into the guide sheath until the tip of the probe juts out of the far end of the sheath (Fig 1, left, 2, and bottom right, 3). Then, the probe and the sheath are bound together at the proximal end of the sheath with cellulose tape so that the tip of the probe remains positioned at the far end of the sheath.
|
After the bronchoscope was advanced beyond the vocal cords, all segments of the bronchial tree were visualized. Based on the radiographic findings, the miniature probe with the guide sheath was negotiated into the bronchus of interest.
The probe was advanced until it reached a point where the operator sensed resistance, and then pulled back for scanning (Fig 2 , top left, 1). When an EBUS image of the lesion could not be obtained, the probe was withdrawn and a curette was inserted into the guide sheath. While retracting the angulated curette with the guide sheath under fluoroscopy, the tip of the curette was moved into another branch of the bronchus. After the angulated curette was advanced into the bronchus leading to the lesion, the curette was withdrawn and once again the probe was inserted into the guide sheath and another attempt made to obtain an EBUS image. Once the location of the lesion was identified precisely by EBUS, the probe was withdrawn, leaving the guide sheath in place (Fig 2, top right, 2).
|
After the brushing forceps was withdrawn, the biopsy forceps was once again introduced into the sheath until the mark on the surface of the forceps reached the end of the sheath. The cups of forceps were opened, and the forceps was advanced 2 or 3 mm into the lesion and the cups closed under imaging guidance. One sufficient biopsy specimen was obtained and placed in formalin.
The guide sheath was left in place for approximately 2 min to put pressure on the biopsy to control bleeding. This procedure is concluded after confirming that hemostasis was achieved.
The amount of bleeding that occurs with guide sheath removal was estimated. Bleeding (
60 mL) was considered severe, and
30 mL was considered moderate when there is no danger to the airway.
Size of the Lesion
The largest dimensions in the anteroposterior and mediolateral directions were measured by CT, and the greatest dimension was defined as the size of the lesion when evaluating effect of size on the diagnostic yield.
Time of Procedure
The total time of EBUS-GS was defined as the time from the insertion of the probe to withdrawal of the guide sheath. The EBUS time was the time that was actually performed EBUS. The fluoroscopy time was calculated as the time was actually being performed.
| Results |
|---|
|
|
|---|
|
2], as it was for benign lesions (24 of 35 lesions [69%] and 19 of 50 lesions [38%], respectively) [p = 0.002,
2]. The lesions in which brushing cytology was negative and TBB was diagnostic included 16 benign lesions and 9 malignant lesions. The 16 benign lesions included 10 cases of organizing pneumonia, each one of abscess, aspergillosis, bronchopneumonia, pneumoconiosis, sarcoidosis, and nonspecific inflammation. The nine malignant lesions included six well-differentiated adenocarcinomas, each one poorly differentiated adenocarcinoma, squamous cell carcinoma, and small cell carcinoma each.
|
2]. The yield by TBB for lesions in which the probe was located within the lesion (85 of 104 lesions, 82%), was very significantly higher than when the probe was adjacent to it (1 of 15 lesions, 7%) [p < 0.0001,
2]. Sixteen nondiagnostic procedures in which the probe was located inside the lesion consisted of six cases of well-differentiated adenocarcinoma, and two cases each of bronchioloalveolar carcinoma, moderately differentiated adenocarcinoma, poorly differentiated adenocarcinoma, actinomycosis, and tuberculosis.
|
30 mm; 92 of 124 lesions, 74%) [p = 0.04,
2]. The diagnostic yield from EBUS-GS for lesions
10 mm (16 of 21 lesions, 76%), >10 to
15 mm (19 of 25 lesions, 76%) [p = 0.99,
2], >15 to
20 mm (24 of 35 lesions, 69%) [p = 0.41,
2], and > 20 to
30 mm (33 of 43 lesions, 77%) [p = 0.96,
2] were similar. When the lesion was
30 mm, size did not affect the yield by EBUS-GS. In other words, the yield for lesions
10 mm did not decrease.
|
20 mm in size. The yield in these lesions was 74% (40 of 54 lesions), and was similar to the yield when it was possible to determine whether the forceps reached to the lesion by fluoroscopy (18 of 27 lesions, 67%) [p = 0.96,
2].
Yield was affected by the location of the lesion (Fig 4
). The yield from the left upper apical posterior segment (6 of 15 lesions, 40%) was significantly lower than that from other locations (p = 0.003,
2).
|
Representative Case
A 74-year-old man had a 10 x 8-mm nodular lesion in segment B5b of the right lung (Fig 5
). Bronchoscopy was performed to confirm the diagnosis of the nodular lesion. A miniature probe covered by the guide sheath was introduced into B5b of the right lung, and pulled back to obtain EBUS images. EBUS revealed heterogeneous internal echoes and a lesion with an irregular margin that contained almost no vessels or bronchi. These findings were suggestive of a solid tumor with a high cell density. The guide sheath was left at the site of the lesion identified by EBUS, and the probe was withdrawn. A bronchial brush and biopsy forceps were introduced into the bronchus. Cytology of the bronchial brushings revealed adenocarcinoma, and TBB confirmed the diagnosis of poorly differentiated adenocarcinoma.
|
| Discussion |
|---|
|
|
|---|
20 mm that are undetectable by fluoroscopy. Although we used EBUS-GS as the procedure for guiding the biopsy procedure instead of fluoroscopy, fluoroscopy was used to search for lesions while manipulating a curette and during the brush biopsy procedure. While 44 lesions were not visible under fluoroscopy, 10 lesions were not imaged by EBUS. We expect EBUS-GS to largely replace fluoroscopy in determining the precise site for bronchoscopic tissue sampling. EBUS-GS was most successful when the probe could be placed within the lesion. The yield of TBB when the probe was adjacent to the lesion was very low (1 of 15 lesions, 7%). This suggests that the lesions visualized as adjacent to the probe may only be in contact with outer surface of the bronchus, and therefore sampling is unlikely to be diagnostic. In this circumstance, the operator should attempt to identify the lesion via another bronchial branch. Nevertheless even when the probe was located within the lesion, 16 lesions could not be diagnosed. Six of these lesions were well-differentiated adenocarcinoma. Here, tumor may not have penetrated the bronchus transmurally. In these cases, the addition of transbronchial needle aspiration might increase the yield.
Chechani17 reported fluoroscopic localization to be most difficult when the lesion is small (< 2 cm) and located in the lower lobe basal segment or the upper lobe apical segment. The diagnostic yield for lesions in these two segments (58%) was lower than yields from all other locations (83%). Fletcher and Levin9 reported the worst yields were from the lower lobe basal segment (2 of 7 lesions, 28%) and superior segment (5 of 19 lesions, 26%). In our EBUS-GS study, the worst yield was noted for lesions in the left upper lobe apical posterior segment (6 of 15 lesions, 40%) [p = 0.003,
2] when compared with yield from all other locations (103 of 135 lesions, 76%). The reason for lower diagnostic yield in the left upper lobe apical posterior segment is thought to be due to the difficulty inserting the probe into B1 + 2. The yield from the lower lobe basal segments was satisfactory (22 of 27 lesions, 81%). Thus, EBUS-GS appears superior to fluoroscopy for localizing lesions in the lower lobe basal segments.
One advantage of EBUS-GS lies in the repeatability of access to the bronchial lesion for sampling. Without a guide sheath, it can be difficult at times to be certain that the forceps are being inserted into the same bronchial branch for the second biopsy. Further, the bronchial mucosa becomes edematous after several attempts at manipulation, and it can be difficult to insert the forceps into the bronchus. Another advantage of EBUS-GS lies in its ability to protect against bleeding into proximal bronchus from the biopsy site. Although massive hemorrhage following TBB is not frequent (< 2%) into the bronchus,1819 excessive bleeding may require hemostasis by wedging the tip of the bronchoscope. If bleeding occurs during EBUS-GS, blood drains through the sheath, because the outer surface of the sheath is snug against the internal surface of the bronchus. In this series of 150 patients, the guide sheath was left in situ for approximately 2 min after completion of the biopsy, and only 2 patients (1%) had moderate bleeding following removal. The final advantage of EBUS-GS is the ability to obtain short-axis bronchial views of peripheral pulmonary lesions. Several investigators have reported the use of a miniature probe. Hürter and Hanarath4 were able to image a peripheral lesion in 19 of 26 patients. In 25 patients, Goldberg and colleagues5 visualized peripheral lung lesions in 6 patients and hilar lesions in 19 patients; they reported that EBUS provided information that could not be obtained by other diagnostic imaging modalities in 18 of 25 patients. Our method of EBUS using a 20-MHz probe allowed visualization of the inner structures of peripheral lesions, including vessels, bronchi, calcifications, necrosis, hemorrhage, and bronchial dilatation.6 We previously reported that peripheral pulmonary lesions could be classified as benign or malignant by EBUS.6 In the representative case, EBUS revealed avascularity and slightly linear or patchy hyperechogenicity. The internal echoes were heterogeneous, with mixed high echoes. These findings identified the lesion as a proliferative solid tumor of high cell density.
Other investigators have described CT-guided bronchoscopy and electromagnetic navigation as new modalities for guiding bronchoscopic biopsies. Asano and colleagues20 reported a diagnostic rate for small peripheral pulmonary lesions (
2 cm) of 78.3% using CT-guided fiberbronchoscopic transbronchial biopsy. Compared with CT-guided fiberbronchoscopic TBB, EBUS-GS offers advantages including simplicity, lack of radiation exposure for patients and staff, and relatively inexpensive equipment. Drawbacks of EBUS-GS include difficulty in selecting the bronchial branch and incapability of visualizing lesions evident as ground-glass attenuation on CT. Schwarz and colleagues21 reported an average registration accuracy for real-time electromagnetic navigation of 4.5 mm; their method represents an accurate technology able to localize peripheral pulmonary lesions. Further studies are needed to determine the yield of transbronchial needle aspiration under EBUS-GS, the feasibility of EBUS-GS without fluoroscopy, and the usefulness of a curette through the guide sheath.
| Conclusion |
|---|
|
|
|---|
| Footnotes |
|---|
Received for publication September 26, 2003. Accepted for publication March 27, 2004.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. D. Sheski and P. N. Mathur Endobronchial Ultrasound Chest, January 1, 2008; 133(1): 264 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yamada, K. Yamazaki, N. Kurimoto, H. Asahina, E. Kikuchi, N. Shinagawa, S. Oizumi, and M. Nishimura Factors Related to Diagnostic Yield of Transbronchial Biopsy Using Endobronchial Ultrasonography With a Guide Sheath in Small Peripheral Pulmonary Lesions Chest, August 1, 2007; 132(2): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshikawa, N. Sukoh, K. Yamazaki, K. Kanazawa, S.-i. Fukumoto, M. Harada, E. Kikuchi, M. Munakata, M. Nishimura, and H. Isobe Diagnostic Value of Endobronchial Ultrasonography With a Guide Sheath for Peripheral Pulmonary Lesions Without X-Ray Fluoroscopy Chest, June 1, 2007; 131(6): 1788 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eberhardt, D. Anantham, F. Herth, D. Feller-Kopman, and A. Ernst Electromagnetic Navigation Diagnostic Bronchoscopy in Peripheral Lung Lesions Chest, June 1, 2007; 131(6): 1800 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Chhajed and M. Tamm Bronchoscopy for small pulmonary nodules and mediastinal staging of lung cancer: just do it! Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 961 - 962. [Full Text] [PDF] |
||||
![]() |
T. R. Gildea, P. J. Mazzone, D. Karnak, M. Meziane, and A. C. Mehta Electromagnetic Navigation Diagnostic Bronchoscopy: A Prospective Study Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 982 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-Y. Chao, C.-H. Lie, Y.-H. Chung, J.-L. Wang, Y.-H. Wang, and M.-C. Lin Differentiating peripheral pulmonary lesions based on images of endobronchial ultrasonography. Chest, October 1, 2006; 130(4): 1191 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sasada, Y. Ogata, M. Kobayashi, T. Hirashima, K. Kawahara, K. Matsui, and I. Kawase Angled Forceps Used for Transbronchial Biopsy in Which Standard Forceps Are Difficult To Manipulate: A Comparative Study Chest, March 1, 2006; 129(3): 725 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Paone, E. Nicastri, G. Lucantoni, R. Dello Iacono, P. Battistoni, A. L. D'Angeli, and G. Galluccio Endobronchial Ultrasound-Driven Biopsy in the Diagnosis of Peripheral Lung Lesions Chest, November 1, 2005; 128(5): 3551 - 3557. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |